ARCH DEVELOPMENT CORPORATION
Patent Owner
Stats
- 153 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jul 08, 2014 most recent publication
Details
- 153 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 14,145 Total Citation Count
- Nov 12, 1981 Earliest Filing
- 250 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8772261 Treatment of tumors with genetically engineered herpes virusOct 19, 12Jul 08, 14[A61K, C12N]
7838512 DNA damaging agents in combination with tyrosine kinase inhibitorsMay 02, 06Nov 23, 10[A61K]
7799535 Methods for identifying factors that control the folding of amyloid proteins of diverse originDec 08, 98Sep 21, 10[C12Q, G01N]
7592317 Constitutive gene expression in conjuction with ionizing radiationAug 11, 94Sep 22, 09[A61K, C12N]
7235366 Methods of identifying agonists and antagonists of opioid receptorsMay 31, 95Jun 26, 07[G01N]
7192711 Compositions and methods involving methyladenosine phosphorylase in the diagnosis and treatment of proliferative disordersMar 22, 05Mar 20, 07[C12Q]
7184582 Method, system and computer readable medium for an intelligent search workstation for computer assisted interpretation of medical imagesMar 08, 04Feb 27, 07[G06K]
7078396 Method of treating disorder related to high cholesterol concentrationNov 08, 02Jul 18, 06[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0164,811 DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORSAbandonedJun 26, 12Jun 27, 13[A61N]
8318691 Treatment of tumors with genetically engineered herpes virusExpiredJun 07, 10Nov 27, 12[A61K]
2012/0135,435 Methods for Identifying Factors That Control the Folding of Amyloid Proteins of Diverse OriginAbandonedAug 11, 10May 31, 12[C12Q, G01N]
2011/0053,240 DNA DAMAGING AGENTS IN COMBINATION WITH TYROSINE KINASE INHIBITORSAbandonedOct 13, 10Mar 03, 11[C12N]
7306801 Methods of therapy for cancers characterized by overexpression of the HER2 receptor proteinExpiredMay 14, 01Dec 11, 07[A61K]
2006/0251,626 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectorsAbandonedJun 09, 06Nov 09, 06[A61K, C12N]
7115258 Vesicular monoamine transporter gene therapy in parkinson's diseaseExpiredOct 31, 02Oct 03, 06[A01N]
7078387 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectorsExpiredDec 28, 99Jul 18, 06[A01N]
2006/0147,907 Methods for detection of promoter polymorphism in a UGT gene promoterAbandonedOct 21, 02Jul 06, 06[C12Q, C12P]
7070968 DNA damaging agents in combination with tyrosine kinase inhibitorsExpiredFeb 24, 03Jul 04, 06[C12N]
6984619 Method for protection against tumor metastasis formationExpiredMar 13, 00Jan 10, 06[A01N, C12Q]
6972196 Making surfaces inert by modifying with alkanethiolatesExpiredOct 11, 00Dec 06, 05[C12Q, C12N]
6916610 Method for generation of longer cDNA fragments from sage tags for gene identificationExpiredDec 22, 00Jul 12, 05[C07H, C12Q, C12P]
6898303 Method, system and computer readable medium for the two-dimensional and three-dimensional detection of lesions in computed tomography scansExpiredJan 16, 01May 24, 05[G06K]
6870037 Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disordersExpiredJul 01, 96Mar 22, 05[C07H, C12Q]
6836558 Method, system and computer readable medium for identifying chest radiographs using image mapping and template matching techniquesExpiredMar 26, 01Dec 28, 04[G06K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.